ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.707,28
-0,87%
S&P 500
5.235,48
-0,60%
US Dollar vs BRL
5,2035
0,00%
Bitcoin
68.290,36
-0,11%
Brent Oil
81,895
-0,07%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Diffusion Pharmaceuticals Inc (DFFN)

  7. Diffusion Pharmaceuticals Inc (DFFN) Notícias

DFFN

Diffusion Pharmaceuticals (DFFN)

Diffusion Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DFFN
DataHoraFonteTítuloCódigoCompanhia
30/05/202418:18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
20/05/202417:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/05/202417:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
10/05/202418:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/04/202417:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
11/04/202420:55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/03/202417:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
06/03/202418:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
28/02/202419:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
09/02/202419:02Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:DFFNDiffusion Pharmaceuticals Inc
09/02/202418:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/09/202317:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/09/202317:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
15/08/202317:01GlobeNewswire Inc.Diffusion Pharmaceuticals Stockholders Approve Merger with EIP PharmaNASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/08/202317:16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/07/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DFFNDiffusion Pharmaceuticals Inc
13/07/202317:32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
23/06/202307:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
19/05/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
15/05/202318:20Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
15/05/202309:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
11/05/202307:05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
03/04/202318:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
30/03/202308:00GlobeNewswire Inc.EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative DiseasesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
24/03/202317:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
16/12/202219:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
16/12/202208:30GlobeNewswire Inc.Diffusion Pharmaceuticals Announces Agreement with LifeSci Special OpportunitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
06/12/202210:31Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prrn14a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
05/12/202208:30GlobeNewswire Inc.Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-DealingNASDAQ:DFFNDiffusion Pharmaceuticals Inc
23/11/202213:27Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)NASDAQ:DFFNDiffusion Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:DFFN

Seu Histórico Recente

NASDAQ
DRCT
Direct Digital
COIN
RGOLDUST
Royal Gold
BIT
P1N9S9
BNP Paribas Issuance
EU
FLUX
Fluxys Belgium
USOTC
GIAFU
GigCapital 5 (PK)
COIN
X2Y2ETH
X2Y2Token
BOV
ELET3M
ELETROBRAS ON
MRTX
LXMTETH
Luxurium
EU
TELW
Amundi Index Solutions
USOTC
SFRTW
Appreciate (CE)
BIT
P1QTS9
BNP Paribas Issuance
COIN
REIIGBP
REI Network
BIT
UI314C
Unicredit Bank
TSXV
CBIT
Cathedra Bitcoin
BMF
ESXZ24
ESXZ24 - Dezembro 2024
TG
LYPD
Amundi MSCI World Financ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados